Predictive index for the onset of medication overuse headache in migraine patients

Neurological Sciences

Volumn 34, Issue 1, 2013, Pages 85-92

  Onaya, T ^a   Ishii, M ^a   Katoh, H ^a   Shimizu, S ^a   Kasai, H ^a   Kawamura, M ^a   Kiuchi, Y ^a  

^a SHOWA UNIVERSITY   (Japan)

Author keywords

Depression; Medication overuse headache; Migraine; Multivariate analysis; Polymorphism; Risk factor

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ANALGESIC AGENT; DOPAMINE 2 RECEPTOR; ERGOTAMINE; NARCOTIC ANALGESIC AGENT; TRIPTAN DERIVATIVE;

ADULT; ARTICLE; CONTROLLED STUDY; DIETARY INTAKE; DISEASE COURSE; DRUG INDUCED HEADACHE; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MIGRAINE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PERSONALITY; QUESTIONNAIRE; SCORING SYSTEM;

ADULT; AGE OF ONSET; DNA PRIMERS; FEMALE; GENOTYPE; HEADACHE DISORDERS, SECONDARY; HUMANS; LIFE STYLE; LOGISTIC MODELS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; MIGRAINE DISORDERS; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; PERSONALITY; PERSONALITY TESTS; POLYMORPHISM, GENETIC; PREDICTIVE VALUE OF TESTS; QUESTIONNAIRES; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, DOPAMINE D2; RISK FACTORS;

EID: 84872684057     PISSN: 15901874     EISSN: 15903478     Source Type: Journal    
DOI: 10.1007/s10072-012-0955-7     Document Type: Article

References (45)

1. HeadacheClassification Committee, Olesen J, Bousser MG, Diener HC, Dodick D, First M, Goadsby PJ, Göbel H, Lainez MJ, Lance JW, Lipton RB, Nappi G, Sakai F, Schoenen J, Silberstein SD, Steiner TJ (2006) New appendix criteria open for a broader concept of chronic migraine. Cephalalgia 26:742-746
2. Imai N, Kitamura E, Konishi T, Suzuki Y, Serizawa M, Okabe T (2007) Clinical features of probable medication-overuse headache: a retrospective study in Japan. Cephalalgia 27:1020-1023
3. Kanki R, Nagaseki Y, Sakai F (2008) Medication-overuse headache in Japan. Cephalalgia 28:1227-1228
4. Sakai F, Igarashi H (1997) Prevalence of migraine in Japan: a nationwide survey. Cephalalgia 17:15-22
5. Meskunas CA, Tepper SJ, Rapoport AM, Sheftell FD, Bigal ME (2006) Medications associated with probable medication overuse headache reported in a tertiary care headache center over a 15-year period. Headache 46:766-772
6. Fanciullacci M, Cesaris FD (2005) Preventing chronicity of migraine. J Headache Pain 6:331-333
7. Ferrari A, Leone S, Valeria A (2007) Similarities and differences between chronic migraine and episodic migraine. Headache 47:65-72
8. Lewis DW (2002) Migraine headache in the adolescent. Adolesc Med 13:413-432
9. Molarius A, Tegelberg A, Ohrvik J (2008) Socio-economic factors, lifestyle, and headache disorders: a population-based study in Sweden. Headache 48:1426-1437
10. Kaji Y, Hirata K (2009) Characteristics of mood disorders in Japanese patients with medication-overuse headache. Inter Med 48:981-986
11. Bienvenu OJ, Nestadt G, Samuels JF, Costa PT, Howard WT, Eaton WW (2001) Phobic, panic, and major depressive disorders and the five-factor model of personality. J Nerv Ment Dis 189:154-161
12. Park JW, Kim JS, Kim YI, Lee KS (2005) Serotonergic activity contributes to analgesic overuse in chronic tension-type headache. Headache 45:1229-1235
13. Cevoli S, Marzocchi N, Capellari S, Scapoli C, Pierangeli G, Grimaldi D, Naldi F, Pini LA, Montagna P, Cortelli P (2010) Lack of association between five serotonin metabolism-related genes and medication overuse headache. J Headache Pain 11:53-58
14. Terrazzino S, Sances G, Balsamo F, Viana M, Monaco F, Bellomo G, Martignoni E, Tassorelli C, Nappi G, Canonico PL, Genazzani AA (2010) Role of 2 common variants of 5HT2A gene in medication overuse headache. Headache 50:1587-1596
15. Headache Classification Subcommittee of the International Headache Society (2004) The international classification of headache disorders: 2nd edition. Cephalalgia 24(Suppl 1):9-160
16. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington American Psychiatric Association Press
17. Costa PT Jr, McCrae RR (1992) Revised NEO personality inventory (NEO-PI-R) and NEO five-factor inventory (NEO-FFI) professional manual. Psychol Assess Resour, Odessa
18. Murakami F, Shimomura T, Kotani K, Ikawa S, Nanba E, Adachi K (1999) Anxiety traits associated with a polymorphism in the serotonin transporter gene regulatory region in the Japanese. J Hum Genet 44:15-17
19. Kaiser R, Muller-Oerlinghausen B, Filler D, Tremblay PB, Berghofer A, Roots I, Brockmoller J (2002) Correlation between serotonin uptake in human blood platelets with the 44-bp polymorphism and the 17-bp variable number of tandem repeat of the serotonin transporter. Am J Med Genet 114:323-328
20. 2A gene and schizophrenia: relation to phenotype and drug response variability. J Psychiatry Neurosci 24:141-146
21. 1B receptor polymorphism and clinical response to sumatriptan. Headache 38:288-291
22. Deckert J, Catalano M, Syagailo YV, Bosi M, Okladnova O, Di Bella D, Nöthen MM, Maffei P, Franke P, Fritze J, Maier W, Propping P, Beckmann H, Bellodi L, Lesch KP (1999) Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. Hum Mol Genet 8:621-624
23. Guo G, Ou XM, Roettger M, Shih JC (2008) The VNTR 2 repeat in MAOA and delinquent behavior in adolescence and young adulthood: associations and MAOA promoter activity. Eur J Hum Genet 16:626-634
24. Hotamisligil GS, Breakefield XO (1991) Human monoamine oxidase A gene determines levels of enzyme activity. Am J Hum Genet 49:383-392
25. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP, Rozen R (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10:111-113
26. Rigat B, Hubert C, Corvol P, Soubrier F (1992) PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res 20:1433
27. Colson NJ, Lea RA, Quinlan S, Griffiths LR (2006) No role for estrogen receptor 1 gene intron 1 Pvu II and exon 4 C325G polymorphisms in migraine susceptibility. BMC Med Genet 7:12
28. Curran JE, Lea RA, Rutherford S, Weinstein SR, Griffiths LR (2001) Association of estrogen receptor and glucocorticoid receptor gene polymorphisms with sporadic breast cancer. Int J Cancer 95:271-275
29. Sarkar G, Kapelner S, Grandy DK, Marchionni M, Civelli O, Sobell J, Heston L, Sommer SS (1991) Direct sequencing of the dopamine D2 receptor (DRD2) in schizophrenics reveals three polymorphisms but no structural change in the receptor. Genomics 11:8-14
30. Shin S, Stewart R, Ferri CP, Kim JM, Shin IS, Kim SW, Yang SJ, Yoon JS (2010) An investigation of associations between alcohol use disorder and polymorphisms on ALDH2, BDNF, 5-HTTLPR and MTHFR genes in order Korean men. Int J Geriatr Psychiatry 25:441-448
31. Kimura K, Iguchi Y, Shibazaki K, Junya A, Terasawa Y (2008) Hemorrhagic transformation of ischemic brain tissue after t-PA thrombolysis as detected by MRI may be asymptomatic, but impair neurological recovery. J Neurol Sci 272:136-142
32. Lee TC, Wang HP, Chiu HM, Lien WC, Chen MJ, Yu LC, Sun CT, Lin JT, Wu MS (2010) Male gender and renal dysfunction are predictors of adverse outcome in nonpostoperative ischemic colitis patients. J Clin Gastroenterol 44:e96-e100
33. Ishii M, Sakairi Y, Hara H, Imagawa A, Shimizu S, Takahashi J, Nagamine A, Naito Y, Masuda Y, Usami S, Kiuchi Y (2011) Negative predictors of clinical response to triptans in patients with migraine. Neurol Sci. doi: 10.1007/s10072-011-0716-z
34. Blount BC, Mack MM, Wehr CM, MacGregor JT, Hiatt RA, Wang G, Wickramasinghe SN, Everson RB, Ames BN (1997) Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci USA 94:3290-3295
35. Duthie SJ, Narayanan S, Brand GM, Pirie L, Grant G (2002) Impact of folate deficiency on DNA stability. J Nutr 132(Suppl):2444S-2449S
36. de Bree A, Verschuren WM, Bjorke-Monsen AL, van der Put NM, Heil SG, Trijbels FJ, Blom HJ (2003) Effect of the methylenetetrahydrofolate reductase 677C->T mutation on the relations among folate intake and plasma folate and homocysteine concentrations in a general population sample. Am J Clin Nutr 77:687-693
37. Miller AL (2008) The methylation, neurotransmitter, and antioxidant connections between folate and depression. Altern Med Rev 13:216-226
38. Koslow SH, Butler IJ (1977) Biogenic amine synthesis defect in dihydropteridine reductase deficiency. Science 198:522-523
39. Hering R, Glover V, Pattichis K, Catarci T, Steiner TJ (1993) 5HT in migraine patients with medication-induced headache. Cephalalgia 13:410-412
40. Rossi C, Pini LA, Cupini ML, Calabresi P, Sarchielli P (2008) Endocannabinoids in platelets of chronic migraine patients and medication-overuse headache patients: relation with serotonin levels. Eur J Clin Pharmacol 64:1-8
41. D'Andrea G, Granella F, Perini F, Farruggio A, Leone M, Bussone G (2006) Platelet levels of dopamine are increase in migraine and cluster headache. Headache 46:585-591
42. Calabresi P, Cupini LM (2005) Medication-overuse headache: similarities with drug addiction. Trends Pharmacol Sci 26:62-68
43. Peroutka SJ, Wilhoit T, Jones K (1997) Clinical susceptibility to migraine with aura is modified by dopamine D2 receptor (DRD2) NcoI alleles. Neurology 49:201-206
44. Gilbody S, Lewis S, Lightfoot T (2007) Methylenetetrahydrofolate reductase (MTHFR) genetic polymorphisms and psychiatric disorders: a HuGE review. Am J Epidemiol 165:1-13
45. Peroutka SJ, Price SC, Wilhoit TL, Jones KW (1998) Comorbid migraine with aura, anxiety, and depression is associated with dopamine D2 receptor (DRD2) NcoI alleles. Mol Med 4:14-21